New CBL-B inhibitors reported in Aurigene Oncology patent
New CBL-B inhibitors reported in Aurigene Oncology patent
المحتوى غير متاح. يرجى الرجوع إلى المصدر الأصلي.
New CBL-B inhibitors reported in Aurigene Oncology patent
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.